5 Results

People

  1. Cordon-Cardo
    Cordon-Cardo
  2. Melamed
    Melamed
  3. Erlandson
    Erlandson
  4. Furth
    Furth
  5. Lewis
    Lewis
  6. Matasar
    Matasar
  7. Old
    Old
  8. Sgouros
    Sgouros

Groups

  1. Center for Hematologic Malignancies (1)
  2. Center for Pancreatic Cancer Research (1)
  3. Department of Medicine (1)
  4. GSK Faculty (1)
  5. Hematologic Malignancies, Division of (1)
  6. Lymphoma (1)
  7. Radiochemistry and Imaging Sciences Service (1)
  8. Radiology, Department of (1)
  9. Survivorship Research (1)
  1. "antibody"
  2. "Meeting abstract"
Formats
  1. Meeting Abstract (5)
Groups
  1. Center for Hematologic Malignancies (1)
  2. Center for Pancreatic Cancer Research (1)
  3. Department of Medicine (1)
  4. GSK Faculty (1)
  5. Hematologic Malignancies, Division of (1)
  6. Lymphoma (1)

More Groups

People
  1. Carlos Cordon-Cardo (2)
  2. Myron Melamed (2)
  3. George Sgouros (1)
  4. Jason Lewis (1)
  5. Lloyd Old (1)
  6. Mark Furth (1)

More People

Years
  1. 2022 (1)
  2. 2017 (1)
  3. 2000 (1)
  4. 1985 (2)
Publications
  1. Proceedings of the American Association for Cancer Research Annual Meeting (2)
  2. Clinical Lymphoma, Myeloma and Leukemia (1)
  3. Journal of Biological Inorganic Chemistry (1)
  4. Journal of Nuclear Medicine (1)
Publishers
  1. American Association for Cancer Research (2)
  2. Elsevier Inc. (1)
  3. Society of Nuclear Medicine (1)
  4. Springer (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mosunetuzumab monotherapy is an effective and well-tolerated treatment option for patients with relapsed/refractory (R/R) follicular lymphoma (FL) who have received ≥2 prior lines of therapy: Pivotal results from a phase I/II study
    Meeting Abstract

    Budde, E. L.; Sehn, L. H.; Matasar, M.; Schuster, S. J.; Assouline, S.; Giri, P.; Kuruvilla, J.; Canales, M.; Dietrich, S.; Fay, K.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Synthetic approaches to novel antibody-gold based drug conjugates for targeted delivery in cancer chemotherapy
    Meeting Abstract

    Le Roi, G. D.; Elie, B. T.; Curado, N.; Lewis, J. S.; Contel, M.
    Journal of Biological Inorganic Chemistry (2017)

    Fulltext@MSK | Save
  • Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: Comparison of Auger electron emitters with beta-particle emitters
    Meeting Abstract

    Govindan, S. V.; Goldenberg, D. M.; Elsamra, S. E.; Griffiths, G. L.; Ong, G. L.; Brechbiel, M. W.; Burton, J.; Sgouros, G.; Mattes, M. J.
    Journal of Nuclear Medicine (2000)

    Fulltext@MSK | Save
  • Oncogene encoded proteins: Human immunoanatomic distrubition and tumor immunopathologic expression
    Meeting Abstract

    Cordon-Cardo, C.; Niman, H. L.; Furth, M. E.; Morrissey, D. M.; Melamed, M. R.; Old, L. J.; Lerner, R. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (1985)

    Fulltext@MSK | Save
  • Distribution, expression and modulation of differentiation antigens in human mesotheliomas. An immunohistochemical and ultrastructural study
    Meeting Abstract

    Li, J. Y.; Cordon-Cardo, C.; Erlandson, R. A.; Melamed, M. R.
    Proceedings of the American Association for Cancer Research Annual Meeting (1985)

    Fulltext@MSK | Save